Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Unity Biotechnology, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
UBX
Nasdaq
2836
unitybiotechnology.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Unity Biotechnology, Inc.
UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates
- Nov 4th, 2024 9:30 pm
UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024
- Sep 24th, 2024 12:00 pm
UNITY Biotechnology to Participate in Upcoming Investor Conferences
- Aug 12th, 2024 12:00 pm
UNITY Biotechnology (UBX) Upgraded to Buy: Here's What You Should Know
- Aug 9th, 2024 4:00 pm
UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial ResultsĀ and Business Updates
- Aug 6th, 2024 8:30 pm
UNITY Biotechnology Reports Granting of New Employment Inducement Award
- Jul 24th, 2024 12:00 pm
UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer
- Jul 22nd, 2024 12:00 pm
Is Unity Biotechnology (NASDAQ:UBX) In A Good Position To Invest In Growth?
- Jul 3rd, 2024 11:27 am
All You Need to Know About UNITY Biotechnology (UBX) Rating Upgrade to Buy
- May 17th, 2024 4:00 pm
UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates
- May 14th, 2024 9:00 pm
UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting
- Apr 25th, 2024 12:00 pm
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME
- Apr 23rd, 2024 12:00 pm
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
- Apr 15th, 2024 11:00 am
New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss
- Feb 6th, 2024 1:00 pm
10 Supplements for Longevity and Antiaging: Expert Recommendations
- Dec 29th, 2023 9:37 pm
UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME
- Dec 12th, 2023 1:00 pm
Companies Like Unity Biotechnology (NASDAQ:UBX) Could Be Quite Risky
- Nov 16th, 2023 11:37 am
Scroll